Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad M Thompson

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Toxicologic Pathology|November 23, 2017
Comparison of Toxicity and Recovery in the Duodenum of B6C3F1 Mice Following Treatment with Intestinal Carcinogens Captan, Folpet, and Hexavalent ChromiumChad M Thompson, Jeffrey C Wolf, Alene McCoy, et al.
Toxicologic Pathology|September 28, 2019
Comparison of Gene Expression Responses in the Small Intestine of Mice Following Exposure to 3 Carcinogens Using the S1500+ Gene Set Informs a Potential Common Adverse Outcome PathwayGrace A Chappell, Julia E Rager, Jeffrey Wolf, et al.
Journal of Applied Toxicology : JAT|August 15, 2013
A chronic oral reference dose for hexavalent chromium-induced intestinal cancerChad M Thompson, Christopher R Kirman, Deborah M Proctor, et al.
Toxicology and Applied Pharmacology|December 14, 2011
Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90days of exposure to hexavalent chromium in drinking waterAnna K Kopec, Suntae Kim, Agnes L Forgacs, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 5, 2017
High-Throughput Screening Data Interpretation in the Context of In Vivo Transcriptomic Responses to Oral Cr(VI) ExposureJulia E Rager, Caroline L Ring, Rebecca C Fry, et al.
Environmental and Molecular Mutagenesis|November 19, 2016
Transcriptomic responses in the oral cavity of F344 rats and B6C3F1 mice following exposure to Cr(VI): Implications for risk assessmentChad M Thompson, Julia E Rager, Mina Suh, et al.
Environmental and Molecular Mutagenesis|May 27, 2015
Assessment of the mutagenic potential of Cr(VI) in the oral mucosa of Big Blue® transgenic F344 ratsChad M Thompson, Robert R Young, Mina Suh, et al.
Critical Reviews in Toxicology|November 4, 2020
An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpetVirunya S Bhat, Samuel M Cohen, Elliot B Gordon, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 21, 2008
Uncertainties in biologically-based modeling of formaldehyde-induced respiratory cancer risk: identification of key issuesRavi P Subramaniam, Chao Chen, Kenny S Crump, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 12, 2018
Identifying Attributes That Influence In Vitro-to-In Vivo Concordance by Comparing In Vitro Tox21 Bioactivity Versus In Vivo DrugMatrix Transcriptomic Responses Across 130 ChemicalsWilliam D Klaren, Caroline Ring, Mark A Harris, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Toxicologic Pathology|November 23, 2017
Comparison of Toxicity and Recovery in the Duodenum of B6C3F1 Mice Following Treatment with Intestinal Carcinogens Captan, Folpet, and Hexavalent ChromiumChad M Thompson, Jeffrey C Wolf, Alene McCoy, et al.
Toxicologic Pathology|September 28, 2019
Comparison of Gene Expression Responses in the Small Intestine of Mice Following Exposure to 3 Carcinogens Using the S1500+ Gene Set Informs a Potential Common Adverse Outcome PathwayGrace A Chappell, Julia E Rager, Jeffrey Wolf, et al.
Journal of Applied Toxicology : JAT|August 15, 2013
A chronic oral reference dose for hexavalent chromium-induced intestinal cancerChad M Thompson, Christopher R Kirman, Deborah M Proctor, et al.
Toxicology and Applied Pharmacology|December 14, 2011
Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90days of exposure to hexavalent chromium in drinking waterAnna K Kopec, Suntae Kim, Agnes L Forgacs, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 5, 2017
High-Throughput Screening Data Interpretation in the Context of In Vivo Transcriptomic Responses to Oral Cr(VI) ExposureJulia E Rager, Caroline L Ring, Rebecca C Fry, et al.
Environmental and Molecular Mutagenesis|November 19, 2016
Transcriptomic responses in the oral cavity of F344 rats and B6C3F1 mice following exposure to Cr(VI): Implications for risk assessmentChad M Thompson, Julia E Rager, Mina Suh, et al.
Environmental and Molecular Mutagenesis|May 27, 2015
Assessment of the mutagenic potential of Cr(VI) in the oral mucosa of Big Blue® transgenic F344 ratsChad M Thompson, Robert R Young, Mina Suh, et al.
Critical Reviews in Toxicology|November 4, 2020
An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpetVirunya S Bhat, Samuel M Cohen, Elliot B Gordon, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 21, 2008
Uncertainties in biologically-based modeling of formaldehyde-induced respiratory cancer risk: identification of key issuesRavi P Subramaniam, Chao Chen, Kenny S Crump, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 12, 2018
Identifying Attributes That Influence In Vitro-to-In Vivo Concordance by Comparing In Vitro Tox21 Bioactivity Versus In Vivo DrugMatrix Transcriptomic Responses Across 130 ChemicalsWilliam D Klaren, Caroline Ring, Mark A Harris, et al.
Pageof 8